Evidence map›Paper›PMID 27559174›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.

Robbert Havekes, Alan J Park, Rosa E Tolentino, Vibeke M Bruinenberg, Jennifer C Tudor, Yool Lee, Rolf T Hansen, Leonardo A Guercio, Edward Linton, Susana R Neves-Zaph and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Green fluorescent cAMP indicator of high speed and specificity suitable for neuronal live-cell imaging.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Robbert HavekesGroningen Institute for Evolutionary Life Sciences, University of Groningen, 9700 AB, Groningen, The Netherlands, Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, r.havekes@rug.nl abele@sas.upenn.edu.ORCID 0000-0003-0757-4739
Alan J ParkDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0002-7644-8886
Rosa E TolentinoDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0002-4261-3230
Vibeke M BruinenbergGroningen Institute for Evolutionary Life Sciences, University of Groningen, 9700 AB, Groningen, The Netherlands.
Jennifer C TudorDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0002-3826-3012
Yool LeeDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0003-0498-3342
Rolf T HansenDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0002-1343-3556
Leonardo A GuercioDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.
Edward LintonDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104.ORCID 0000-0001-7058-9576
Susana R Neves-ZaphDepartments of Pharmacology and Systems Therapeutics, Friedman Brain Institute, and System Biology Center New York, Icahn School of Medicine at Mount Sinai, New York, New York 10029.
Peter MeerloGroningen Institute for Evolutionary Life Sciences, University of Groningen, 9700 AB, Groningen, The Netherlands.
George S BaillieInstitute of Cardiovascular and Medical Science, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom, and.ORCID 0000-0003-2469-6316
Miles D HouslayInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, United Kingdom.ORCID 0000-0002-3826-8091
Ted AbelDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, r.havekes@rug.nl abele@sas.upenn.edu.ORCID 0000-0003-2423-4592
University of Pennsylvania · USUniversity of Groningen · NLTranslational Therapeutics (United States) · USAllen Institute for Brain Science · USKing's College London · GBUniversity of Glasgow · GB

Funding

University of Pennsylvania Postdoctoral Opportunities in Research and TeachingK12GM081259 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Janis K. Burkhardt · 2007 to 2026
$20.1M
THE ROLE OF SLEEP IN MEMORY STORAGEP01AG017628 · NIA · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 2001 to 2017
$19.2M
Dynamics Underlying Tissue IntegrityR01DK087650 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HE, JOHN CIJIANG, HONE, JAMES C · 2009 to 2013
$6.7M
Tools to conditionally regulate intracellular signaling pathways in vivoR01MH086415 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ABEL, EDWIN TED G. · 2009 to 2013
$2.3M
Medical Research Council MR/J007412/1NIA NIH HHS P01 AG017628NIDDK NIH HHS R01 DK087650NIGMS NIH HHS K12 GM081259NIMH NIH HHS R01 MH086415
6 · The paper itself

Abstract

unlabelledAlterations in cAMP signaling are thought to contribute to neurocognitive and neuropsychiatric disorders. Members of the cAMP-specific phosphodiesterase 4 (PDE4) family, which contains >25 different isoforms, play a key role in determining spatial cAMP degradation so as to orchestrate compartmentalized cAMP signaling in cells. Each isoform binds to a different set of protein complexes through its unique N-terminal domain, thereby leading to targeted degradation of cAMP in specific intracellular compartments. However, the functional role of specific compartmentalized PDE4 isoforms has not been examined in vivo Here, we show that increasing protein levels of the PDE4A5 isoform in mouse hippocampal excitatory neurons impairs a long-lasting form of hippocampal synaptic plasticity and attenuates hippocampus-dependent long-term memories without affecting anxiety. In contrast, viral expression of a truncated version of PDE4A5, which lacks the unique N-terminal targeting domain, does not affect long-term memory. Further, overexpression of the PDE4A1 isoform, which targets a different subset of signalosomes, leaves memory undisturbed. Fluorescence resonance energy transfer sensor-based cAMP measurements reveal that the full-length PDE4A5, in contrast to the truncated form, hampers forskolin-mediated increases in neuronal cAMP levels. Our study indicates that the unique N-terminal localization domain of PDE4A5 is essential for the targeting of specific cAMP-dependent signaling underlying synaptic plasticity and memory. The development of compounds to disrupt the compartmentalization of individual PDE4 isoforms by targeting their unique N-terminal domains may provide a fruitful approach to prevent cognitive deficits in neuropsychiatric and neurocognitive disorders that are associated with alterations in cAMP signaling. SIGNIFICANCE STATEMENT: Neurons exhibit localized signaling processes that enable biochemical cascades to be activated selectively in specific subcellular compartments. The phosphodiesterase 4 (PDE4) family coordinates the degradation of cAMP, leading to the local attenuation of cAMP-dependent signaling pathways. Sleep deprivation leads to increased hippocampal expression of the PDE4A5 isoform. Here, we explored whether PDE4A5 overexpression mimics behavioral and synaptic plasticity phenotypes associated with sleep deprivation. Viral expression of PDE4A5 in hippocampal neurons impairs long-term potentiation and attenuates the formation of hippocampus-dependent long-term memories. Our findings suggest that PDE4A5 is a molecular constraint on cognitive processes and may contribute to the development of novel therapeutic approaches to prevent cognitive deficits in neuropsychiatric and neurocognitive disorders that are associated with alterations in cAMP signaling.

Indexed as

Analysis of VarianceAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cells, CulturedColforsinConditioning, ClassicalCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4Electric StimulationEnzyme-Linked Immunosorbent AssayFearFluorescence Resonance Energy TransferGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsHippocampusMaleCalcium-Calmodulin-Dependent Protein Kinase Type 2ColforsinCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4enhanced green fluorescent proteinGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsPde4a protein, mouseProtein IsoformsVasodilator AgentscAMPhippocampusLTPmemoryPDEphosphodiesterase

Identifiers

PMID27559174
PMCPMC4995304
OpenAlexW2515602394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.